MedAdvisor Appoints John Ciccio as CEO and Managing Director

MedAdvisor (ASX: MDR) has announced the appointment of John Ciccio as its new Chief Executive Officer and Managing Director, with outgoing CEO Rick Ratliff stepping aside but remaining in an advisory role to ensure a smooth leadership transition.

Ciccio is no stranger to MedAdvisor. He brings a cumulative 12 years of experience with Adheris Health, MedAdvisor’s US subsidiary, including three years as President and CEO from 2019 to 2022. During that period, he led the business through a significant transformation, notably launching the intelligent patient management platform THRiV, and increasing US revenues from 25 million dollars to nearly 40 million dollars.

MedAdvisor Interim Chair Kate Hill said the Board was confident Ciccio would provide steady and decisive leadership from the outset.

“His previous experience with the company, particularly during the rebuilding phase from 2019 to 2022, gives him a deep understanding of our operations, people, and strategic priorities,” Hill said. “John is well known and highly respected across the industry for his integrity, focus, and track record of delivering results.”

Outgoing CEO Rick Ratliff departs after three and a half years in the top job, during which MedAdvisor divested its ANZ business, cleared all debt, expanded its health program pipeline, and implemented a major technology transformation that is due to be finalised in early 2026.

“MedAdvisor is in a strong competitive position and I am very proud of what we have achieved together,” Ratliff said. “It is the right time to hand over leadership to John, who brings a long history of contributing to the company’s success.”

In response, Ciccio said he was looking forward to working with the team to continue building value for patients and partners.

“I want to thank Rick for his leadership and the strong technology foundation he has built during his time at MedAdvisor,” he said. “He leaves the company poised for future growth.”

Ciccio’s career spans several leadership roles in healthcare technology and commercial strategy. He previously co-founded Rota Health, served as Chief Operating Officer of Technology and Data at Syneos Health, and was President and board member of Skipta, a professional network for healthcare providers.

Under the terms of his appointment, Ciccio will receive a base salary starting at 325 thousand US dollars, rising to 425 thousand US dollars by January 2027 upon meeting agreed performance hurdles. He is also eligible for 30 million options with a three cent strike price, subject to shareholder approval and performance conditions. There is no short term incentive component for the first 18 months, and his contract includes a six month notice period and a 12 month post employment restraint.

With this change, MedAdvisor signals a renewed strategic focus on its US operations and continued development of its technology platform. The company reaches over two thirds of the US population through its network of more than 34,000 partner pharmacies, and its AI-enabled platform THRiV is positioned to power future growth in pharmacy-led patient engagement.